Personal information

Other IDs

Scopus Author ID: 26666723100
ResearcherID: E-2789-2014

Activities

Collapse all

Employment (1)

Universidade Estadual Paulista Júlio de Mesquita Filho: Araçatuba, SP, BR

2015-02-23 to 2016-02-23 | Substitute professor (Pathology)
Employment
Source: Self-asserted source
Camargo MR

Education and qualifications (5)

Universidade de São Paulo Faculdade de Odontologia de Bauru: Bauru, SP, BR

2017-05-01 to present | Pos doctorate (Clinical, stomatology, radiology and Pathology)
Education
Source: Self-asserted source
Camargo MR

Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Botucatu: Botucatu, SP, BR

2010-03-01 to 2014-02-28 | PhD (Pathology)
Education
Source: Self-asserted source
Camargo MR

University of Maryland Baltimore County: Baltimore, MD, US

2013-01-06 to 2013-06-07 | Part of my PhD (Biological Sciences)
Education
Source: Self-asserted source
Camargo MR

Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Botucatu: Botucatu, SP, BR

2008-02-01 to 2010-02-26 | Masters dregree (Pathology)
Education
Source: Self-asserted source
Camargo MR

Universidade Estadual Paulista Júlio de Mesquita Filho: Bauru, SP, BR

2003-03-15 to 2007-12-15 | Undergraduation (Biological Sciences)
Education
Source: Self-asserted source
Camargo MR

Funding (2)

Ganoderma lucidum polysaccharides and cell senescence in tongue squamous cell carcinoma

2019-12-01 to 2020-10-31 | Grant
São Paulo Research Foundation (São Paulo, BR)
URL: https://app.dimensions.ai/details/grant/grant.9071946
GRANT_NUMBER: 19/20314-6
Source: Self-asserted source
Camargo MR via DimensionsWizard

Anti tumoral action of Ganoderma lucidum polysaccharides in tongue squamous cell carcinoma

2018-08-01 to 2019-07-31 | Grant
São Paulo Research Foundation (São Paulo, BR)
URL: https://app.dimensions.ai/details/grant/grant.9075825
GRANT_NUMBER: 18/04203-7
Source: Self-asserted source
Camargo MR via DimensionsWizard

Works (12)

Ganoderma lucidum polysaccharides inhibit in vitro tumorigenesis, cancer stem cell properties and epithelial-mesenchymal transition in oral squamous cell carcinoma

Journal of Ethnopharmacology
2022 | Journal article
DOI: 10.1016/J.JEP.2021.114891
WOSUID: WOS:000789636500005
Contributors: de Camargo, Marcela Rodrigues; Frazon, Talita Fonseca; Inacio, Kelly Karina; Smiderle, Fhernanda Ribeiro; Amor, Nadia Ghinelli; Dionisio, Thiago Jose; Santos, Carlos Ferreira; Rodini, Camila Oliveira; Lara, Vanessa Soares
Source: check_circle
Web of Science Researcher Profile Sync

Low Dose Of 5-Fluorouracil Combined with A Dendritic Cell Vaccine Delays the Growth of Colorectal Cancer in Mice

Biomed J Sci & Tech Res
2020-08 | Journal article
Source: Self-asserted source
Camargo MR

Role of diet and gut microbiota on colorectal cancer immunomodulation

World Journal of Gastroenterology
2018-01-14 | Journal article
DOI: 10.3748/wjg.v25.i2.151
Part of ISSN: 1007-9327
Source: Self-asserted source
Camargo MR

Low Concentration of 5-Fluorouracil Increases the Effectiveness of Tumor RNA to Activate Murine Dendritic Cells

Cancer Biotherapy and Radiopharmaceuticals
2017 | Journal article
DOI: 10.1089/CBR.2017.2259
WOSUID: WOS:000413337900005
Contributors: de Camargo, Marcela Rodrigues; Gorgulho, Carolina Mendonca; Rodrigues, Cecilia Pessoa; Penitenti, Marcimara; Longo Frederico, Juliana Cristina; Marchesan Rodrigues, Maria Aparecida; Kaneno, Ramon
Source: check_circle
Web of Science Researcher Profile Sync

Pesticide dichorvos induces early solid Ehrlich tumoral development associated with a non-protective pro-inflammatory response

Environmental Science and Pollution Research
2017 | Journal article
DOI: 10.1007/s11356-017-1104-x
Source: Self-asserted source
Camargo MR

Low concetration of 5-Fluorouracil increases the effectiveness of tumor RNA to activate murine dendritic cells

Cancer Biotherapy and radiopharmaceuticals
2017-09-19 | Journal article
DOI: E-2789-2014
Source: Self-asserted source
Camargo MR

Macrophage activity and histopathology of the lymphohematopoietic organs in male Wistar rats orally exposed to single or mixed pesticides

Journal of Environmental Science and Health, Part B
2013-07 | Journal article
DOI: 10.1080/03601234.2013.775020
Part of ISSN: 0360-1234
Part of ISSN: 1532-4109
Source: Self-asserted source
Camargo MR
grade
Preferred source (of 3)‎

Dermatophyte-host relationship of a murine model of experimental invasive dermatophytosis

Microbes and Infection
2012 | Journal article
DOI: 10.1016/j.micinf.2012.07.014
EID:

2-s2.0-84868109723
Contributors: Venturini, J.; Álvares, A.M.; de Camargo, M.R.D.; Marchetti, C.M.; Fraga-Silva, T.F.D.C.; Luchini, A.C.; de Arruda, M.S.P.
Source: Self-asserted source
Camargo MR via Scopus - Elsevier
grade
Preferred source (of 2)‎

Antitumor properties of Ganoderma lucidum polysaccharides and terpenoids

Annual Review of Biomedical Sciences
2011 | Journal article
EID:

2-s2.0-84856297897
Contributors: Camargo, M.R.; Kaneno, R.
Source: Self-asserted source
Camargo MR via Scopus - Elsevier

Influence of tumour condition on the macrophage activity in candida albicans infection

Scandinavian Journal of Immunology
2009 | Journal article
DOI: 10.1111/j.1365-3083.2009.02260.x
EID:

2-s2.0-67649801095
Contributors: Venturini, J.; De Camargo, M.R.; Félix, M.C.; Vilani-Moreno, F.R.; De Arruda, M.S.P.
Source: Self-asserted source
Camargo MR via Scopus - Elsevier
grade
Preferred source (of 2)‎

Modulation of macrophage cytokine profiles during solid tumor progression: Susceptibility to Candida albicans infection

BMC Infectious Diseases
2009 | Journal article
DOI: 10.1186/1471-2334-9-98
EID:

2-s2.0-67650392064
Contributors: Camargo, M.R.; Venturini, J.; Vilani-Moreno, F.R.; Arruda, M.S.P.
Source: Self-asserted source
Camargo MR via Scopus - Elsevier
grade
Preferred source (of 2)‎

Immunotherapy Approaches Focusing on Cancer Stem Cells
Source: check_circle
Web of Science Researcher Profile Sync

Peer review (4 reviews for 3 publications/grants)

Review activity for Journal of Applied Oral Science. (1)
Review activity for Pharmacological research. (1)
Review activity for Technology in cancer research & treatment. (2)
How many people are using ORCID?